CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma
Clinical trial NCT07575893 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07575893
- Sponsor
- New York Medical College
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2031-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.